Bluejay Diagnostics, Inc. (BJDX)
NASDAQ: BJDX · Real-Time Price · USD
0.6964
-0.0481 (-6.46%)
At close: Oct 19, 2026, 4:00 PM EDT
0.6964
0.00 (0.00%)
Pre-market: Oct 20, 2026, 4:00 AM EDT
Bluejay Diagnostics Employees
Bluejay Diagnostics had 6 employees as of December 31, 2025. The number of employees decreased by 1 or -14.29% compared to the previous year. That makes Bluejay Diagnostics the 41,239th largest employer in the world and 6,363rd in the United States.
Employees
6
Change (1Y)
-1
Growth (1Y)
-14.29%
Revenue / Employee
n/a
Profits / Employee
-$1,211,783
Market Cap
3.11M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 6 | -1 | -14.29% |
| Dec 31, 2024 | 7 | -3 | -30.00% |
| Dec 31, 2023 | 10 | -6 | -37.50% |
| Dec 31, 2022 | 16 | 7 | 77.78% |
| Dec 31, 2021 | 9 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Vivos Therapeutics | 270 |
| WORK Medical Technology Group LTD | 238 |
| Co-Diagnostics | 115 |
| IceCure Medical | 69 |
| Intelligent Bio Solutions | 60 |
| VolitionRx | 57 |
| INVO Fertility | 42 |
| Adagio Medical Holdings | 41 |
BJDX News
- 6 days ago - Bluejay Achieves Toray Contractual Manufacturing Milestone, Advancing Supply-Chain Resilience and Commercialization Readiness - Accesswire
- 13 days ago - Bluejay Diagnostics announces SYMON-II clinical validation study details - TheFly
- 13 days ago - Bluejay Diagnostics Announces SYMON-II Clinical Dataset Details Supporting Evaluation of Mortality Risk in Sepsis and Septic Shock - Accesswire
- 5 weeks ago - Bluejay Diagnostics and Lovell Government partner to access federal healthcare - TheFly
- 5 weeks ago - Bluejay Diagnostics and Lovell Government Services Announce Partnership to Expand Access to U.S. Federal Healthcare Markets - GlobeNewsWire
- 2 months ago - Bluejay Diagnostics Reports Q2 2026 Results; Strengthened Balance Sheet Supports Advancement of Symphony™ IL-6 Toward Regulatory Submission and Commercialization - GlobeNewsWire
- 3 months ago - Bluejay Diagnostics completes enrollment in SYMON-II study - TheFly
- 3 months ago - Bluejay Diagnostics Announces Successful Completion of Enrollment in the SYMON-II Multicenter Clinical Validation Study - GlobeNewsWire